- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
VIDEO — HEXO CEO: Aggressive Pursuit of Clean Balance Sheet Has Reset Company
INN spoke with Charlie Bowman, the newly appointed CEO of Canadian cannabis producer HEXO.
It’s been a seriously difficult period for Canadian cannabis operators over the past few years, with volatility prevailing as the status quo for companies in the market.
Charlie Bowman, president and CEO of HEXO (NASDAQ:HEXO,TSX:HEXO), understands that, and that’s why his first order of business after taking the helm at the company was to clean up its finances. He sees a better path ahead for HEXO now that it has restructured its assets and had its debt purchased by a fellow Canadian producer.
Bowman spoke at length with the Investing News Network (INN) about the downturn in Canadian cannabis stocks, HEXO’s NASDAQ listing status and its partnership with Tilray Brands (NASDAQ:TLRY,TSX:TLRY).
Canadian cannabis sentiment faces downturn
The executive told INN he thinks mistakes from the past at HEXO are still affecting its present. His goal is to reset the company in his role as CEO, and this has started with its debt.
Bowman explained that the company's previous acquisition spree, particularly the structuring of debt to complete those deals, acted to “(drive) the stock price down.”
This year, HEXO announced a partnership through which Tilray ended up buying senior secured convertible notes issued by HEXO with a balance of US$173.7 million.
However, Tilray purchased the notes for US$155 million, resulting in a 10.8 percent discount.
According to the operators, as of July 11, the conversion price of the HEXO notes gives Tilray the right to convert into about 48 percent of the outstanding common stock of HEXO.
“What it allows us to do is, there’s certain synergies that the partnership … can potentially bring to the market,” the executive commented in conversation with INN.
Update on NASDAQ listing requirement
Shares of HEXO have seriously lagged for some time now, including in the US as part of its NASDAQ listing. The American listing carries a standard requirement of a minimum price per share of US$1.
In late July, the firm announced it had obtained an additional grace period from securities regulators to meet this listing requirement. The company now has until January 23, 2023, to regain the mandated compliance.
“That was the curveball as soon as I had taken on,” Bowman said, describing HEXO's challenges since he stepped up as CEO. He believes cost-cutting measures and the firm's realignment will lead to NASDAQ compliance.
Watch the entire video above to hear the rest of Bowman’s comments about the future of HEXO. You can also click here to subscribe to our YouTube channel and keep up with all our expert interviews.
Don’t forget to follow us @INN_Cannabis for real-time updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.
Bryan is a Senior Editor with INN. After graduating from the Langara journalism program he did some freelance reporting with community newspapers in British Columbia. He initially wrote about the life science space for INN and now spends his time covering the marijuana market, from Canadian LPs to US-based companies, and the impact of this sector on investors.
Learn about our editorial policies.